Table 3 Statistical analysis of cost of screening annually against the current 2.5 years
From: Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Time of screening | Cost per patients diagnosed | QALY | ICER annual against 2.5 years | QALY increment | |
|---|---|---|---|---|---|
Any DR | 1 year | €1347.89 | 12.05 | €1096.88 | 0.77 |
2.5 years | €482.32 | 11.28 | |||
STDR | 1 year | €4270.98 | 11.27 | €4571.2 | 0.60 |
2.5 years | €1528.26 | 10.67 | |||
DMO | 1 year | €5099.91 | 11.87 | €7443.28 | 0.44 |
2.5 years | €1824.82 | 11.43 |